| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It is engaged in the development of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, It generates a majority of its revenue from the United Kingdom.
| |